The Patent Finder

Terms ending in 2039

Allergan, Inc.

Every in-force patent on Allergan, Inc.'s record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 11,890,457Aspiration and Injection Device
In force
 · High confidence
Allergan, Inc.In forceHigh confidence
US 10,610,518Presbyopia Treatments
In force
 · High confidence
Allergan, Inc.In forceHigh confidence
US 11,285,134Presbyopia Treatments
In force
 · High confidence
Allergan, Inc.In forceHigh confidence
US 11,096,958Sodium Chlorite Compositions with Enhanced Anti-Microbial Efficacy and Reduced Toxicity
In force
 · High confidence
Allergan, Inc.In forceHigh confidence
US 11,738,043Sodium Chlorite Compositions with Enhanced Anti-Microbial Efficacy and Reduced Toxicity
In force
 · High confidence
Allergan, Inc.In forceHigh confidence
US 12,527,816Sodium Chlorite Compositions with Enhanced Anti-Microbial Efficacy and Reduced Toxicity
In force
 · Medium confidence
Allergan, Inc.In forceMedium confidence
US D1,027,647Bottle Holder
In force
 · High confidence
Allergan, Inc.In forceHigh confidence
US 12,383,545Treatment of Migraine
In force
 · High confidence
Allergan Pharmaceuticals International LimitedIn forceHigh confidence
US 10,787,447Pharmaceutical Compounds
In force
 · High confidence
Nxera Pharma UK LimitedIn forceHigh confidence
US 10,858,352Pharmaceutical Compounds
In force
 · High confidence
Nxera Pharma UK LimitedIn forceHigh confidence
4 more term ends in 2039 · Pro
10 of 14 patents shown. Soonest term end first, then patent number.
Pro members see all 14.
Upgrade to Pro
10 of these are in force and held by Allergan, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited